Skip to content

Bilateral Recto-Intercostal Fascial Plane Block in Epigastric Hernia Repair

Efficacy and Safety of Bilateral Recto-Intercostal Fascial Plane Block on Perioperative Analgesia in Epigastric Hernia Repair : A Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06092073
Enrollment
40
Registered
2023-10-23
Start date
2023-10-21
Completion date
2026-05-31
Last updated
2026-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Epigastric Hernia, Recto-intercostal Fascial Plane Block

Brief summary

The aim of this study is to evaluate the efficacy and safety bilateral recto-intercostal fascial plane block (RIFPB) in epigastric hernia.

Detailed description

Epigastric hernias are usually occult in obese patients, and their symptoms may mimic peptic ulcer or gallbladder disease . Hernia repair is associated with considerable postoperative pain. The recto-intercostal fascial plane block (RIFPB) is a new novel approach that was developed by Tulgar et al., 2023 who hypothesized that when we inject a local anesthetic into the interfacial plane just inferolateral to the xiphoid, between the rectus abdominis muscle and the 6-7th costal cartilages (hence, between the cartilages and the intercostal muscles between them), blockade of the anterior branches of the nerves passing through this area can be guaranteed.

Interventions

Patients will receive bilateral recto-intercostal fascial plane block using 20 mL of bupivacaine 0.25% on each side.

DRUGbupivacaine

bupivacaine 0.25%

Sponsors

Tanta University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-65 years. * Both sexes. * American Society of Anesthesiology (ASA) physical status I-II. * Scheduled for elective epigastric hernia repair.

Exclusion criteria

* Obese patients with body mass index (BMI) \>35 kg/m2. * Patients with a large hernia containing bowel. * Patients with local anesthetic allergy.

Design outcomes

Primary

MeasureTime frameDescription
Time to the 1st rescue analgesia24 hours postoperativelyRescue analgesia in the form of 3 mg of IV morphine will be given if the numeric rating scale (NRS) score \> 3. NRS (0 represents "no pain" while 10 represents "the worst pain imaginable").

Secondary

MeasureTime frameDescription
Total morphine consumption in the 1st 24hr24 hours postoperativelyRescue analgesia in the form of 3 mg of IV morphine will be given if the numeric rating scale (NRS) score\> 3.
Pain score24 hours postoperativelyEach patient will be instructed about postoperative pain assessment with the Numeric Rating Scale (NRS) score. NRS (0 represents "no pain" while 10 represents "the worst pain imaginable"). Postoperative pain using NRS at rest and during coughing or movement will be measured at PACU, 2h. 4hr, 6h, 8h, 12h, 18h and 24h postoperative
Intraoperative fentanyl consumptionIntraoperatively.Additional bolus doses of fentanyl 1 µg/kg IV will be given if there is increase in heart rate or mean arterial blood pressure more than 20% of the base line (after exclusion of other causes than pain).
Intraoperative mean arterial pressureTill the end of surgery.Mean arterial pressure (MAP) will be recorded preoperative, before performing of block, and every 15 min till the end of surgery.
Intraoperative heart rateTill the end of surgery.Heart rate (HR) will be recorded preoperative, before performing of block, and every 15 min till the end of surgery.
Complications24 hours postoperativelySuch as pneumothorax, nausea, vomiting, hematoma, hypotension, bradycardia and local anesthetic toxicity will be recorded.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 15, 2026